Effect of exercise on serum androgens in postmenopausal women: A 12-month randomized clinical trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 7, 2004, Pages 1099-1105

  McTiernan, Anne ^a,b,c   Tworoger, Shelley S ^a,b   Rajan, Kumar B ^a,b   Yasui, Yutaka ^a   Sorenson, Bess ^a   Ulrich, Cornelia M ^a,b   Chubak, Jessica ^a,b   Stanczyk, Frank Z ^f   Bowen, Deborah ^a   Irwin, Melinda L ^d   Rudolph, Rebecca E ^a,c   Potter, John D ^a,b   Schwartz, Robert S ^e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TESTOSTERONE;

ADULT; AGED; ANDROGEN BLOOD LEVEL; ARTICLE; BODY FAT; BREAST CANCER; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FEMALE; HUMAN; NORMAL HUMAN; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SITTING; UNITED STATES;

ADIPOSE TISSUE; AGED; ANDROGENS; BODY MASS INDEX; BODY WEIGHT; BREAST NEOPLASMS; EXERCISE; FEMALE; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RADIOIMMUNOASSAY; TESTOSTERONE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 3142703018     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chlebowski RT. Reducing the risk of breast cancer. N Engl J Med 2000;343:191-8.
2. Friedenreich CM. Physical activity and cancer prevention: from observational to intervention research. Cancer Epidemiol Biomarkers & Prev 2001;10:287-301.
3. McTiernan A, Kooperberg C, White E, et al. A prospective study of recreational physical activity and the risk of breast cancer in women aged 50-79 years: the Women's Health Initiative cohort study. JAMA 2003;290:1331-6.
4. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-31.
5. Kaye SA, Folsom AR, Soler JT, Prineas RJ, Potter JD. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int J Epidemiol 1991;20:151-6.
6. Newcomb PA, Klein R, Klein BER, et al. Association of dietary and lifestyle factors with sex hormones in postmenopausal women. Epidemiology 1995;6:318-21.
7. Corbould AM, Judd SA, Rogers RJ. Expressions of types 1, 2, and 3 17β-hydroxysteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women. J Clin Metab Endocrinol 1998;83:187-94.
8. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16.
9. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr 1987;45:277-82.
10. Irwin M, Yasui Y, Ulrich CM, et al. Effect of moderate- and vigorous-intensity exercise on total and intra-abdominal body fat in postmenopausal women: a one-year randomized controlled trial. JAMA 2003;289:323-30.
11. McTiernan A, Ulrich C, Yancey D, et al. The Physical Activity for Total Health (PATH) study: rationale and design. Med Sci Sports Exer 1999;31:1307-12.
12. Tworoger S, Yasui Y, Ulrich C, et al. Mailing strategies and recruitment into an intervention trial of the exercise effect on breast cancer biomarkers. Cancer Epidemiol Biomarkers & Prev 2002;11:73-7.
13. Ainsworth BE, Haskell WL, Whitt MC, et al. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exer 2000;32:S498-516.
14. Patterson R, Kristal A, Tinker L, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol 1999;9:178-87.
15. Taylor H, Jacobs D, Shucker B, et al. A questionnaire for the assessment of leisure-time physical activities. J Chronic Dis 1978;31:741-55.
16. Shuman WP. Abnormal body fat distribution in diabetic males. Invest Radiol 1986;21:483-7.
17. Goebelsmann U, Bernstein GS, Gale JA, et al. Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. In: Lepow IH, Crozier R, editors. Vasectomy: immunologic and pathophysiologic effects in animals and man. New York: Academic Press; 1979. p. 165.
18. Probst-Hensch NM, Ingles SA, Diep AT, et al. Aromatase and breast cancer susceptibility. Endocr Relat Cancer 1999;6:165-73.
19. Sodergard R, Backstrom T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to human plasma protein at body temperature. J Steroid Biochem 1982; 26:801-10.
20. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84:3666-72.
21. Rinaldi S, Geay A, Déchaud H, et al. Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations. Cancer Epidemiol Biomarkers & Prev 2002;11:1065-107.
22. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
23. Lobo RA. Androgens in postmenopausal women: production, possible role, and replacement options. Obstet Gynecol Surv 2001;56:361-76.
24. Corbould AM, Bawden MJ, Lavranos TC, Rodgers RJ, Judd SJ. The effect of obesity on the ratio of type 3 17β-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women. Int J Obes Relat Metab Disord 2002;26:165-75.
25. Burd ID, Bachmann GA. Androgen replacement in menopause [review]. Curr Womens Health Rep 2001;1:202-5.
26. Notelovitz M. Androgen effects on bone and muscle. Fertil Steril 2002;77 Suppl:34-41.
27. Davis SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab 2001;12:33-7.